Shan; Weifang
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shan; Weifang.The latest application filed is for "inhibitors of indoleamine 2,3-dioxygenase and methods of their use".
Company Profile
17.25.29
- Shan; Weifang - Princeton NJ
Patent Activity
| Patent | Date |
|---|---|
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,337,970 - Cherney , et al. May 24, 2 | 2022-05-24 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210355113 - BALOG; James Aaron ; et al. | 2021-11-18 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210299126 - BALOG; James Aaron ; et al. | 2021-09-30 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210290613 - CHERNEY; Emily Charlotte ; et al. | 2021-09-23 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,066,392 - Balog , et al. July 20, 2 | 2021-07-20 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,066,383 - Williams , et al. July 20, 2 | 2021-07-20 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210206723 - BALOG; James Aaron ; et al. | 2021-07-08 |
| Compounds Useful As Inhibitors Of Helios Protein App 20210147383 - DEGNAN; Andrew P. ; et al. | 2021-05-20 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,696,648 - Williams , et al. June 30, 2 | 2020-06-30 |
| IDO inhibitors Grant 10,689,331 - Balog , et al. | 2020-06-23 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,633,342 - Cherney , et al. | 2020-04-28 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200095231 - BALOG; James Aaron ; et al. | 2020-03-26 |
| Immunoregulatory agents Grant 10,533,014 - Beck , et al. Ja | 2020-01-14 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,932 - Balog , et al. Sep | 2019-09-03 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,933 - Balog , et al. Sep | 2019-09-03 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,323,004 - Shan , et al. | 2019-06-18 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190144416 - WILLIAMS; David K. ; et al. | 2019-05-16 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190135758 - CHERNEY; Emily Charlotte ; et al. | 2019-05-09 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190119215 - SHAN; Weifang ; et al. | 2019-04-25 |
| Immunoregulatory agents Grant 10,206,893 - Beck , et al. Feb | 2019-02-19 |
| Ido Inhibitors App 20190002402 - Balog; James Aaron ; et al. | 2019-01-03 |
| Immunoregulatory Agents App 20190002472 - Beck; Hilary Plake ; et al. | 2019-01-03 |
| IDO inhibitors Grant 10,167,254 - Balog , et al. J | 2019-01-01 |
| Immunoregulatory Agents App 20180325889 - BECK; Hilary Plake ; et al. | 2018-11-15 |
| Immunoregulatory agents Grant 10,106,546 - Beck , et al. October 23, 2 | 2018-10-23 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180079712 - Balog; James Aaron ; et al. | 2018-03-22 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180072660 - Balog; James Aaron ; et al. | 2018-03-15 |
| IDO inhibitors Grant 9,790,169 - Balog , et al. October 17, 2 | 2017-10-17 |
| Ido Inhibitors App 20170231999 - Balog; James Aaron ; et al. | 2017-08-17 |
| Immunoregulatory Agents App 20170197973 - Beck; Hilary Plake ; et al. | 2017-07-13 |
| Immunoregulatory Agents App 20170143649 - Beck; Hilary Plake ; et al. | 2017-05-25 |
| Immunoregulatory agents Grant 9,643,972 - Beck , et al. May 9, 2 | 2017-05-09 |
| IDO inhibitors Grant 9,624,188 - Balog , et al. April 18, 2 | 2017-04-18 |
| Immunoregulatory agents Grant 9,598,422 - Beck , et al. March 21, 2 | 2017-03-21 |
| Ido Inhibitors App 20160289171 - Balog; James Aaron ; et al. | 2016-10-06 |
| Immunoregulatory Agents App 20160137653 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Immunoregulatory Agents App 20160137652 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Ido Inhibitors App 20160060237 - Balog; James Aaron ; et al. | 2016-03-03 |
| Tricyclic heterocycle compounds Grant 9,249,157 - Shan , et al. February 2, 2 | 2016-02-02 |
| Fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,133,139 - Gavai , et al. September 15, 2 | 2015-09-15 |
| Tricyclic Heterocycle Compounds App 20150246930 - Shan; Weifang ; et al. | 2015-09-03 |
| Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150218111 - Gavai; Ashvinikumar V. ; et al. | 2015-08-06 |
| Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function Grant 8,466,171 - Shan , et al. June 18, 2 | 2013-06-18 |
| Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function Grant 8,067,582 - Norris , et al. November 29, 2 | 2011-11-29 |
| Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20100331324 - Norris; Derek J. ; et al. | 2010-12-30 |
| Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20100256180 - Shan; Weifang ; et al. | 2010-10-07 |
| Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function Grant 7,468,439 - Shan , et al. December 23, 2 | 2008-12-23 |
| Fused cyclic modulators of nuclear hormone receptor function Grant 7,432,267 - Salvati , et al. October 7, 2 | 2008-10-07 |
| Alkylene Bridged Sultam Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20080090883 - Shan; Weifang ; et al. | 2008-04-17 |
| Fused cyclic modulators of nuclear hormone receptor function Grant 7,001,911 - Salvati , et al. February 21, 2 | 2006-02-21 |
| Fused cyclic modulators of nuclear hormone receptor function App 20050282813 - Salvati, Mark E. ; et al. | 2005-12-22 |
| Fused cyclic modulators of nuclear hormone receptor function App 20040077606 - Salvati, Mark E. ; et al. | 2004-04-22 |
| Fused cyclic modulators of nuclear hormone receptor function App 20030114420 - Salvati, Mark E. ; et al. | 2003-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 